Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: KMBJN. who wrote (12394)	11/5/2019 5:16:41 PM
From: hpgrant	Respond to of 12873

Exactly what I've been thinking. The deal is not necessarily catastrophic for NNVC. But it's certainly not what I would have wanted to negotiate. Of course, Dr. Diwan the Greater is a fierce negotiator when he's across the table from Dr. Diwan the Lesser. It's just a good thing they left the table on speaking terms.

To: KMBJN. who wrote (12394)	11/5/2019 5:46:04 PM
From: drkaz	Respond to of 12873

Agreed - we do need to have a grasp of what their base materials, production expenses, and packaging/shipping expenses are in order to know how much would be left for NNVC and those of us holding that bag. The lower their production costs,... the better for us all. One potential advantage does remain - as this is a chemistry production system, and not some biological fermentation or cell-culture-based production system, it is probably very scalable. And the greater the quantity they can manufacture, and the lower the effective dosing for that amount of product,... the better it may be. Diwan is still going to make out like a bandit - but if we end up with a significant benefit as well - I can live with that.